GP681 Powder for Oral Suspension

· Jiangxi Qingfeng Pharmaceutical Co. Ltd.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for GP681 Powder for Oral Suspension, covering 2025-03-18 to 2025-03-18. Get the full timeline:

Most recent: Clinical Trial Update: Study to Assess the Tolerability, Safety and Efficacy of GP681 Powder for Oral Suspension [Phase 1]